Barclays, Keeps

Barclays Keeps Sell Rating on CSG as Defence Group Pushes Into Space and Armour

Published on 10/23/2026 at 14:31 | Editorial boerse-global.de
Barclays reaffirms sell on CSG with a 19.00-euro target, as CSG shows the Meander prototype and holds a 9.5% MDA Space stake.
Barclays Keeps Sell Rating on CSG as Defence Group Pushes Into Space and Armour Illustration mit AI erstellt.

Barclays has reaffirmed its bearish stance on CSG, with analyst Afonso Osorio sticking to a sell recommendation and a price target of 19.00 euros, according to media reports on Tuesday. The call sets up a contrast with the defence group's recent expansion moves, and it lands ahead of the company's next scheduled update to investors.

The distinction matters for anyone reading the note. CSG's current share price of 13.72 euros sits below the 19.00-euro target, but that gap does not soften the verdict: Osorio is still advising clients to sell. Price target and rating should be weighed separately, since the target on its own cannot be read as a positive view on the stock. Focusing solely on the distance between market price and target would obscure the explicitly negative recommendation, which remains the central message of yesterday's analyst action.

Meander Prototype Shown in Prague

On the corporate side, CSG unveiled the Meander, an amphibious tracked vehicle for military use, on Wednesday. The prototype was developed jointly by CSG subsidiary Excalibur Army and New Space Technologies, a company belonging to Krill Business Partners. CSG said the vehicle, designed for operations on land and on water, was presented in its transport configuration at the Future Forces Forum in Prague.

Investors should keep product launches and commercial returns apart. The presentation makes a concrete development result visible, but it does not amount to an order. The announcement centres on the vehicle and on cooperation among the companies involved.

Should investors sell immediately? Or is it worth buying CSG?

MDA Space Stake Comes With Its Own Team

Roughly two weeks ago, on 13 October, CSG announced the acquisition of a 9.5% stake in MDA Space, making it the largest shareholder in the company. CSG described the investment as its entry into the space sector. According to the company, the holding could pave the way for further cooperation, with possible fields including manufacturing or assembly facilities in Europe and strategic acquisitions. Those are options for future development, not follow-on projects already decided.

Alongside the stake, CSG announced a dedicated space team, including newly created roles for space strategy and technology as well as for corporate development in the space segment. The move into space therefore combines the share purchase with the build-out of organisational responsibilities.

The two announcements carry different weight. Meander represents a development project that has been shown publicly. At MDA Space, the stake acquisition and the organisational steps are completed or announced, while deeper industrial cooperation remains a possibility rather than an agreed partnership.

CSG at a turning point? This analysis reveals what investors need to know now.

November Update Becomes the Next Test

CSG opened registration on Monday for the presentation of its nine-month report for 2026, scheduled for 11 November 2026 at 10:00 CET. That makes business performance the next checkpoint for investors. Product launches and equity stakes sketch out the strategic direction; the upcoming report offers the next concrete occasion to judge those activities against actual trading.

Until then, Barclays' confirmed sell rating stands alongside the company's announcements as a cautious signal on valuation.

Ad

CSG Stock: New Analysis - 23 October

Fresh CSG information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated CSG analysis...

Disclaimer...
en | NL0015073TS8 | BARCLAYS | boerse | 70399020 |